Science.

This is the place to learn all about the science behind our services – from general background about antibodies, to details about our unique technology, to real world problems that our clients have solved.

Latest post:

When Hybridomas Die: Recovering Critical Reagents with Antibody Sequencing

Live Webinar

October 7, 2025 | 10:00AM EST

Rethinking Epitope-Based Patents for Stronger mAb Protection

Fill out the form to register

Featured Posts

All posts >>

Applications

Webinars

Monthly webinar series featuring guest speakers and technology deep dives. View on demand.

View on demand

Case studies

Studies, publications, posters and technical notes that used our services and technology to achieve great things.

Literature review

Browse by application area

Find content about your specific industry niche – e.g. antibody discovery, protein engineering, IVD, veterinary medicine, etc.

Applications pages

Rapid Novor Technology

Synthetic Antigens Enable CAR-T Cell Targeting of Solid Tumors

Developing CAR-T Therapies Against Novel Cancer Antigens

SPR vs. ELISA: SPR Guides Accurate ELISA Results

More about our technology >>

Antibody Learning Center

Anti-Idiotypic Antibodies in Drug Development

Disulfide Bond Engineering

Major Histocompatibility Complex Therapeutic Applications

Visit the learning center >>

Press Releases & News

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Genya Gorshtein2025-08-01T10:46:59-04:00Tags: News|

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

Genya Gorshtein2025-08-01T10:46:59-04:00Tags: News|

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

Mingjie Xie2025-08-01T10:46:59-04:00Tags: News|

More news >>

Upcoming Conferences.

View All Upcoming COnferences

Talk to Our Scientists.

We Have Sequenced 10,000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Science.

When Hybridomas Die: Recovering Critical Reagents with Antibody Sequencing

Live Webinar

October 7, 2025 | 10:00AM EST

Rethinking Epitope-Based Patents for Stronger mAb Protection

Featured Posts

All posts >>

Applications

Webinars

Case studies

Browse by application area

Rapid Novor Technology

Synthetic Antigens Enable CAR-T Cell Targeting of Solid Tumors

Developing CAR-T Therapies Against Novel Cancer Antigens

SPR vs. ELISA: SPR Guides Accurate ELISA Results

More about our technology >>

Antibody Learning Center

Anti-Idiotypic Antibodies in Drug Development

Disulfide Bond Engineering

Major Histocompatibility Complex Therapeutic Applications

Visit the learning center >>

Press Releases & News

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

More news >>

Upcoming Conferences.

Talk to Our Scientists.

We Have Sequenced 10,000+ Antibodies and We Are Eager to Help You.

Services

Science

About

Other programs

Services

Applications

Science

About